Navigation Links
Maker of leading in-home HIV test encourages testing
Date:11/6/2012

HOFFMAN ESTATES, Ill., Nov. 6, 2012 /PRNewswire/ -- Home Access Health Corporation, manufacturer of at-home laboratory test services, today said that individuals interested in obtaining an easy-to-use in-home HIV test that offers anonymity, confirmed results in a single day, and professional counseling should turn to its Home Access® Express HIV-1 Test System.

"In-home testing for HIV can inform persons at risk for HIV and AIDS about their health status and help reduce HIV transmission rates," said Mary Vogt, President of Home Access Health Corporation.  "We encourage testing, but believe strongly that any in-home testing provide the user with accurate, confirmed results quickly; as well as high-quality counseling by trained professionals that directs users to qualified medical care."

Increasingly, Vogt said, medical professionals and HIV activists, while recognizing the value of increased HIV testing, have raised concerns about the recently introduced over-the-counter rapid HIV test that relies on oral fluid rather than the more reliable fingerstick blood sample.  The drawbacks, they say, include lack of trained HIV counselors and medical care referrals, as well as inaccurate results that may lead people to believe erroneously that they are free of infection.

The concerns are legitimate, says Vogt, whose Home Access® Express HIV-1 Test System was approved for in-home use by the Food and Drug Administration (FDA) in 1996.  "Accurate results and professional counseling are a must.  Results offered without the benefit of counseling can be devastating,"

The anonymous Home Access® Express HIV-1 test system is greater than 99.9 percent accurate, and detects HIV-1 by using a fingerstick blood sample collected by the user. The sample is sent overnight to a certified testing laboratory using FDA-approved assays.  Preliminary positive results are confirmed and results are available by telephone the next business day using an anonymous 1-800 number.  Users of the test have immediate access to degreed and bilingual social workers who offer results, counseling and medical referrals.  

Home Access recently launched HIVhometestfacts.com, a website offering information about over-the-counter HIV tests currently on the market.  The website is designed to help the public understand the two at-home testing options, their rates of accuracy and their differences, Vogt said. HIVhometestfacts.com compares the in-home HIV tests, and provides questions and answers and additional resources on HIV/AIDS education and support. 

The Home Access® Express HIV-1 Test System is available at major pharmacies including Walgreens, CVS and Rite-Aid, as well as online at Drugstore.com and at www.homeaccess.com.

In-home HIV test users should be aware there is a period of time – the "window" period -- during which individuals who are positive will still test negative, Home Access Health said.  Blood-based HIV tests have a shorter window period than oral fluid tests.   The Centers for Disease Control and Prevention say the "window" period can range from 4-6 weeks to 6 months.  Persons who believe they have been exposed to HIV should have repeat testing.

For information on the in-home HIV test market, visit HIVhometestfacts.com today.

About Home Access Health Corporation

Home Access Health Corporation (HAHC) was founded in 1993 to provide anonymous, direct-to-consumer laboratory test services using self-collected fingerstick blood.  Individuals collect, package and send a small fingerstick blood specimen to the Company's CAP-accredited laboratory, using components provided in the Home Access test kits.  HAHC received FDA approval for its HIV-1 Test System in 1996 and immediately launched a national consumer awareness campaign.

In 1998, responding to the U.S. Surgeon General's order for public health departments (and other healthcare entities) to combat Hepatitis C (HCV), the company adapted its HIV platform and fast-tracked clinical trials and regulatory filings, resulting in an FDA approval for Home Access® Hepatitis C Check test service in 1999.  HAHC markets its HCV test primarily through public health departments.

In 2007, the Company received FDA clearance for its complete Cholesterol Panel, a comprehensive laboratory test system that uses self-collected fingerstick blood to measure total cholesterol, HDL-cholesterol, Triglycerides and LDL-cholesterol.  The accuracy levels of the Cholesterol Panel achieve the standards established by the National Cholesterol Education Program and the test method has been certified by the CDC-sponsored National Cholesterol Reference Method Laboratory Network.

The Home Access FDA-approved test system for HIV-1 and Hepatitis C are sold directly to consumers without the need for physician intervention. (http://www.fda.gov/consumer/updates/hivtestkit012908.html).  These tests are anonymous, include confirmatory testing, and access to the HAHC counseling center for results delivery, counseling, and referrals.


'/>"/>
SOURCE Home Access Health Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Laboratory Decision Makers Cautiously Optimistic about Funding Conditions, Finds Frost & Sullivan
2. Omeros to Present at the 19th Annual Newsmakers in the Biotech Industry Conference
3. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
4. BioSpace Spotlights Leading Life Science Community
5. Northwest Bio Reaffirms Its Freedom to Operate; Refutes Other Parties Misleading Patent Assertions
6. iBioSeminars and iBioMagazine: Free, Online Biology Seminars and Short Talks by Leading Scientists
7. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
8. Johns Hopkins Health System is 100th healthcare Provider to Integrate OnBase With Leading Electronic Medical Record System
9. Leading German Researcher Awarded Elseviers 2011 Tetrahedron Prize
10. Dyadic International Partners with Leading Provider of Nutritional Ingredient Solutions for Production of Food Enzymes
11. Floridas Leading Fertility Center Announces Successful Baby Delivery via Egg Freezing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Cumberland Foreside, Maine (PRWEB) , ... January 17, ... ... to announce the addition of Rheumatoid Factor (RF) to its VALIDATE® SP2 calibration ... and Rheumatoid Factor in a human serum base. Each VALIDATE® SP2 kit is ...
(Date:1/17/2017)... DIEGO , Jan. 17, 2017  An ... School of Medicine and St. Boniface Hospital Albrechtsen ... for peripheral neuropathy, an unmet health need affecting ... the Journal of Clinical Investigation, their results identify ... that prevent and reverse neuronal injury in animal ...
(Date:1/17/2017)... 2017   Pulmatrix, Inc . (NASDAQ: ... inhaled therapies to address serious pulmonary diseases, today announced ... the lungs of CF patients, PUR1900, has been designated ... U.S. Food & Drug Administration. Under ... the development of novel drugs against important pathogens, Pulmatrix ...
(Date:1/17/2017)...  Only nine percent of U.S. consumers believe pharmaceutical ... 16 percent believe health insurance companies do, according to ... of U.S. adults believe health care providers (such as ... hospitals (23%). "We are in the midst ... , vice president of reputation management and public affairs ...
Breaking Biology Technology:
(Date:12/15/2016)... , Dec. 14, 2016 "Increase in mobile ... market" The mobile biometrics market is expected to grow ... billion by 2022, at a CAGR of 29.3% between ... such as the growing demand for smart devices, government ... "Software component is expected to grow at ...
(Date:12/7/2016)... , December 7, 2016 According to a new market ... Software Tool (Facial Expression, Voice Recognition), Service, Application Area, End User, And Region ... to grow from USD 6.72 Billion in 2016 to USD 36.07 Billion by ... Continue Reading ... MarketsandMarkets ...
(Date:12/6/2016)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (the "Company") ... million principal amount of its 1.414% senior unsecured notes due ... unsecured notes due 2026. The closing of ... to the satisfaction of customary closing conditions.  The notes will ... The Company intends to use the net proceeds from ...
Breaking Biology News(10 mins):